ClinicalTrials.gov
public full text
Public Domain
A Study of Baricitinib (LY3009104) in Participants With COVID-19
The reason for this study is to see if the study drug baricitinib is effective in hospitalized participants with COVID-19.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.#123572
- A Study of Baricitinib (LY3009104) in Healthy Chinese Participants#993838
- A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers#1281243
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID#969451
- Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects#903286
Record · ID 1372504
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive